Imaging Endpoints Founder Discusses Role in PharmaCyte Biotech’s Unique Approach to Pancreatic Cancer for Upcoming Clinical Trial
October 05, 2015 09:25 ET
|
PharmaCyte Biotech, Inc.
SILVER SPRING, Md., Oct. 05, 2015 (GLOBE NEWSWIRE) -- PharmaCyte Biotech, Inc. (OTCQB:PMCB), a clinical stage biotechnology company focused on developing targeted treatments for cancer and...
PharmaCyte Biotech Retains Industry Expert to Monitor Short Sellers and Market Makers
October 01, 2015 09:25 ET
|
PharmaCyte Biotech, Inc.
SILVER SPRING, Md., Oct. 01, 2015 (GLOBE NEWSWIRE) -- PharmaCyte Biotech, Inc. (OTCQB:PMCB), a clinical stage biotechnology company focused on developing targeted treatments for cancer and...
PharmaCyte Biotech’s Encapsulation Technology Could Address Unmet Medical Need
September 28, 2015 09:25 ET
|
PharmaCyte Biotech, Inc.
SILVER SPRING, Md., Sept. 28, 2015 (GLOBE NEWSWIRE) -- PharmaCyte Biotech, Inc. (OTCQB:PMCB), a clinical stage biotechnology company focused on developing targeted treatments for cancer and...
PharmaCyte Biotech Hires Industry-Leading Firm to Assist With Investigational New Drug Application
September 25, 2015 09:25 ET
|
PharmaCyte Biotech, Inc.
SILVER SPRING, Md., Sept. 25, 2015 (GLOBE NEWSWIRE) -- PharmaCyte Biotech, Inc. (OTCQB:PMCB), a clinical stage biotechnology company focused on developing targeted treatments for cancer and...
PharmaCyte Biotech Discusses Pancreatic Cancer Treatment for Upcoming Phase 2b Human Clinical Trial
September 22, 2015 10:41 ET
|
PharmaCyte Biotech, Inc.
SILVER SPRING, Md., Sept. 22, 2015 (GLOBE NEWSWIRE) -- PharmaCyte Biotech, Inc. (OTCQB:PMCB), a clinical stage biotechnology company focused on developing targeted treatments for cancer and...
PharmaCyte Biotech Discusses Major Milestones Ahead of Phase 2b Clinical Trial in Pancreatic Cancer
September 15, 2015 09:30 ET
|
PharmaCyte Biotech, Inc.
SILVER SPRING, Md., Sept. 15, 2015 (GLOBE NEWSWIRE) -- PharmaCyte Biotech, Inc. (OTCQB:PMCB), a clinical stage biotechnology company focused on developing targeted treatments for cancer and...
PharmaCyte Biotech Begins Phase 2b Clinical Trial Push With Imaging Endpoints Contract for Radiological Imaging
September 09, 2015 09:30 ET
|
PharmaCyte Biotech, Inc.
SILVER SPRING, Md., Sept. 09, 2015 (GLOBE NEWSWIRE) -- PharmaCyte Biotech, Inc. (OTCQB:PMCB), a clinical stage biotechnology company focused on developing targeted treatments for cancer and...
PharmaCyte Biotech Executives Interviewed on Role of Leaders in Oncology for Development of Its Clinical Trials
September 02, 2015 09:00 ET
|
PharmaCyte Biotech, Inc.
SILVER SPRING, Md., Sept. 02, 2015 (GLOBE NEWSWIRE) -- PharmaCyte Biotech, Inc. (OTCQB:PMCB), a clinical stage biotechnology company focused on developing targeted treatments for cancer and...
PharmaCyte Biotech Announces Successful Completion of Interim Audit of GMP Facility for the Production of Cell-in-a-Box for Clinical Trials
August 25, 2015 09:38 ET
|
PharmaCyte Biotech, Inc.
SILVER SPRING, Md., Aug. 25, 2015 (GLOBE NEWSWIRE) -- PharmaCyte Biotech, Inc. (OTCQB:PMCB), a clinical stage biotechnology company focused on developing targeted treatments for cancer and...
PharmaCyte Biotech’s Scientific Advisory Board Members Co-Author Major Review on Pancreatic Cancer
August 19, 2015 09:00 ET
|
PharmaCyte Biotech, Inc.
SILVER SPRING, Md., Aug. 19, 2015 (GLOBE NEWSWIRE) -- PharmaCyte Biotech, Inc. (OTCQB:PMCB), a clinical stage biotechnology company focused on developing targeted treatments for cancer and...